Main content area

Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice

Huai, Jisen, Firat, Elke, Nil, Ahmed, Million, Daniele, Gaedicke, Simone, Kanzler, Benoit, Freudenberg, Marina, van Endert, Peter, Kohler, Gabriele, Pahl, Heike L., Aichele, Peter, Eichmann, Klaus, Niedermann, Gabriele
Proceedings of the National Academy of Sciences of the United States of America 2008 v.105 no.13 pp. 5177-5182
CD8-positive T-lymphocytes, apoptosis, cell senescence, fibroblasts, hematopoiesis, inflammation, knockout mutants, longevity, mice, neoplasm cells, phenotype, proteinases, transcription factor NF-kappa B
The giant cytosolic protease tripeptidyl peptidase II (TPPII) has been implicated in the regulation of proliferation and survival of malignant cells, particularly lymphoma cells. To address its functions in normal cellular and systemic physiology we have generated TPPII-deficient mice. TPPII deficiency activates cell type-specific death programs, including proliferative apoptosis in several T lineage subsets and premature cellular senescence in fibroblasts and CD8⁺ T cells. This coincides with up-regulation of p53 and dysregulation of NF-κB. Prominent degenerative alterations at the organismic level were a decreased lifespan and symptoms characteristic of immunohematopoietic senescence. These symptoms include accelerated thymic involution, lymphopenia, impaired proliferative T cell responses, extramedullary hematopoiesis, and inflammation. Thus, TPPII is important for maintaining normal cellular and systemic physiology, which may be relevant for potential therapeutic applications of TPPII inhibitors.